MILTON S. HERSHEY MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $12.1M
- Transactions
- 1,261
- Companies
- 40
- Average per transaction
- $9,562
Who reported the payments
| AbbVie | $2,470,033 |
| Merck | $1,534,332 |
| Pfizer | $1,424,758 |
| Y-mabs Therapeutics, Inc. | $684,168 |
| Takeda Pharmaceuticals U.S.A., Inc. | $668,448 |
| Actuated Medical, Inc. | $620,631 |
| Fujirebio Diagnostics, Incorporated | $505,831 |
| Intuitive Surgical | $436,282 |
| Novartis | $381,834 |
| Medtronic | $283,376 |
| Insulet Corporation | $269,125 |
| CSL Behring | $243,296 |
| Acutus Medical, Inc. | $234,000 |
| Adlon Therapeutics L.p. | $221,580 |
| Elekta Instrument AB | $212,154 |
| Incyte Corporation | $175,924 |
| Purdue Pharma L.p. | $155,020 |
| Tandem Diabetes Care, Inc. | $133,525 |
| Relievant Medsystems, Inc. | $124,741 |
| Siemens Medical Solutions USA, Inc. | $112,280 |
| Carl Zeiss Meditec Production LLC | $88,337 |
| Medical Device Business Services, Inc. | $75,000 |
| Olympus America Inc. | $73,981 |
| Stryker | $73,692 |
| Erbe Elektromedizin GmbH | $67,800 |
| Bristol Myers Squibb | $52,406 |
| UCB SA | $50,984 |
| M.a. Med Alliance S.A. | $50,528 |
| Bard Peripheral Vascular, Inc. | $49,628 |
| Biocryst Pharmaceuticals, Inc. | $48,273 |
| Spark Therapeutics, Inc. | $47,823 |
| Biosense Webster, Inc. | $45,000 |
| Amgen | $44,389 |
| Mizuho America, Inc. | $39,251 |
| Biofire Diagnostics, LLC | $34,672 |
| Aesculap Biologics, LLC | $29,275 |
| Leadiant Biosciences, Inc. | $26,612 |
| Biomerieux Inc | $19,510 |
| Quidel Corporation | $19,447 |
| Carl Zeiss Meditec, Inc. | $14,400 |